Platelet

Tomato extract shows blood thinning potential versus aspirin: Study

23-Nov-2016 By Shane Starling

A proprietary tomato extract – backed in EU health claim law to benefit blood circulation – has been shown to thin blood in healthy people – but less severely than aspirin and without typical side-effects.

Curcumin bioavailability boosted 7x: Industry study

26-Jun-2014 By Nicola Cottam

The bioavailability of micronutrients in a proprietary curcuminoid formulation is seven times more potent than 95% pure curcuminoids, say researchers from the Indian manufacturer Olive Lifesciences.

Heart benefits of phenolic compounds not physiologically relevant, says study

05-Oct-2011 By Nathan Gray

Research has called into question the role of plant polyphenols in cardiovascular health, by finding that their supposed anti-platelet activities are only relevant at high, and physiologically unattainable, concentrations.

Provexis tomato extract claim approved by EC

17-Dec-2009 By Shane Starling

More than six months after receiving a positive health claim opinion from the European Food Safety Authority (EFSA) linking its tomato extract to blood circulation benefits, UK biotech firm Provexis has been handed final claim wording by the European...

Virgin olive oil polyphenols reduce platelet aggregation: rat study

12-Sep-2008 By Shane Starling

Spanish researchers have shown that virgin olive oil (VOO) extracts can benefit heart and circulation health by reducing platelet aggregation in a study conducted on rats.

Unilever, Provexis carve deal for Fruitflow spreads

15-Nov-2007 By Jess Halliday

Functional ingredient innovator Provexis has secured a new 12-month
deal with Unilever to investigate the use of its Fruitflow
technology in the multinational's spreads brands.

Coca-Cola to give Provexis fizz with Fruitflow deal?

12-Oct-2007 By Alex McNally

A deal between Provexis and Coca-Cola over the use of its
tomato-based Fruitflow technology could be on the cards, according
to The Times, which may see heart health functional drinks
propelled into the mainstream.

Provexis seeks funding stop-gap for further Fruitflow development

03-Jan-2007 By Jess Halliday

Provexis is seeking to raise new funds to bolster its working
capital, after depleting its coffers with the extended timeline for
developing an advanced form of its Fruitflow technology.

Fruitflow discussions hit delay but Provexis still confident

06-Nov-2006 By Jess Halliday

Provexis has extended discussions over the use of its Fruitflow
tomato-based bioactive by a major global food company into 2007, as
it continues to tweak the technology platform to make it suitable
for a spectrum of food products.

Black tea may speed up recovery from stress

05-Oct-2006 By Stephen Daniells

Drinking black tea could reduce stress hormone levels and help ease
the burden of heart disease, says the first randomized clinical
trial into the effects of the beverage on stress.

Tomato extract could stop platelet build-up, boost heart health

25-Sep-2006 By staff reporter

Extracts from tomatoes offer heart health benefits by reducing the
accumulation of platelets that lead eventually to blood clots,
heart attacks and strokes, say two complimentary studies from the
UK.

Sirco model smoothes Provexis' route to negotiations

16-Jun-2006 By Jess Halliday

The strategy of demonstrating the potential of new technology with
an own-brand launch in order to garner interest from major industry
players seems to be paying off for Provexis, which has progressed
with global licensing discussions...

Tomato juice appears to thin blood in diabetics

19-Aug-2004

Drinking tomato juice everday reduced the blood's clotting ability
in people with type 2 diabetes, report Australian researchers this
week.

Tomato extract to quicken the blood

12-Sep-2003

UK firm Provexis looks set to release a novel heart-healthy drink
next year after recent human trials on its tomato-based product
proved successful. CardioFlow is a concentrated tomato extract but
it contains no lycopene.